Tag: oncology ablation market demand

Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

Oncology Ablation Market Expected To Reach $2.61 Billion By 2030 At 12.4% CAGR

The oncology ablation sector has experienced substantial expansion lately, projected to increase from $1.45 billion in 2025 to $1.64 billion in 2026, reflecting a compound annual growth rate of 12.5%. This upward trajectory in the historical period is linked to several factors: a greater incidence of liver, kidney, and lung cancers; amplified interest in less invasive medical procedures; the broader accessibility of sophisticated imaging equipment; the development of healthcare facilities, including hospitals and dedicated cancer centers; and a heightened recognition of ablation as a viable substitute for surgical interventions.

The global market for oncology ablation is poised for substantial expansion over the coming years, projected to reach $2.61 billion by 2030, exhibiting a compound annual growth rate of 12.4%. This anticipated surge in the forecast period is largely fueled by advancements in targeted and personalized ablation treatments, a heightened embrace of minimally invasive percutaneous and laparoscopic approaches, continuous technological innovation in ablation devices, the proliferation of oncology centers in developing economies, and the increasing integration of digital tools for patient management and post-procedural monitoring. Key market developments expected during this timeframe encompass a greater adoption of digital platforms for managing oncology ablation procedures, the growing incorporation of artificial intelligence and machine learning in tumor diagnosis and treatment planning, a wider application of precision medicine and genomic profiling to tailor ablation therapies, increasing automation in ablation equipment and surgical tools, and a rise in Internet of Things (IoT) enabled devices for monitoring ablation procedures and patient results.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18415&type=smp

Oncology Ablation Market Growth Drivers: What Factors Are Accelerating Expansion?

The expanding prevalence of cancer detection is set to stimulate advancements within the oncology ablation market. Cancer diagnosis entails the systematic identification and verification of malignancy, employing medical examinations, sophisticated imaging techniques, and thorough pathological assessments of bodily tissues. This upward trend in cancer diagnoses can be attributed to a confluence of elements, including an expanding elderly demographic, more effective screening methodologies, elevated public consciousness fostering earlier identification, and various environmental influences. Oncology ablation serves as a critical intervention for addressing tumors identified through these diagnostic processes, providing less invasive methods to eradicate cancerous growths and enhance patient prognoses. Illustratively, by May of 2024, projections from the National Cancer Institute, a leading US federal entity dedicated to cancer research and education, indicated an anticipated 2,001,140 new cancer diagnoses within the United States for that year, with prostate, lung, and colorectal cancers accounting for approximately 48% of the total diagnoses among males. Looking ahead to 2040, the yearly incidence of new cancer cases is anticipated to escalate dramatically to 29.9 million, underscoring a substantial prospective surge in cancer affliction rates globally. Moreover, in June 2022, data from the American Cancer Society, a prominent US non-profit focused on cancer awareness, revealed that roughly 1.9 million new cancer cases were identified in the USA during 2022. Consequently, the growing volume of cancer detections is poised to be a primary catalyst for the oncology ablation market’s expansion.

Oncology Ablation Market Segment Landscape And Growth Potential

The oncology ablation market covered in this report is segmented –

1) By Technology: Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation

2) By Treatment: Surgical Ablation, Laparoscopic Ablation, Percutaneous Ablation

3) By Application: Kidney Cancer, Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer

Subsegments:

1) By Radiofrequency Ablation: Monopolar Radiofrequency Ablation, Bipolar Radiofrequency Ablation

2) By Microwave Ablation: Single-Probe Microwave Ablation, Multi-Probe Microwave Ablation

3) By Cryoablation: Cryo-Needle Ablation, Cryo-Generator System Ablation

4) By Irreversible Electroporation Ablation: Transurethral IRE, Transperineal IRE, Percutaneous IRE

Oncology Ablation Market Trends: What Is Shaping Future Industry Growth?

Within the oncology ablation market, leading enterprises are actively engaged in creating cutting-edge solutions, encompassing sophisticated ablation systems engineered for greater accuracy, imaging capabilities that offer dynamic guidance, and heightened safety attributes. These state-of-the-art ablation systems represent medical instruments employing sophisticated techniques to accurately target and eradicate malignant growths, such as tumors, while concurrently preserving adjacent healthy tissue. A notable illustration of this progress occurred in March 2024, when Medtronic Plc, a prominent medical device manufacturer headquartered in Ireland, secured approval from the U.S. Food and Drug Administration for its OsteoCool 2.0 bone tumor ablation system, a device intended for the treatment of painful bone metastases

Oncology Ablation Market Competitive Landscape: Who Are The Leading Companies?

Major companies operating in the oncology ablation market are Medtronic plc, Boston Scientific Corporation, AngioDynamics Inc, EDAP TMS S.A., Merit Medical Systems Inc, Misonix Inc, BSD Medical Corporation, Sonacare Medical, Chongqing Haifu Medical Technology Co Ltd, HealthTronics Inc, Galil Medical Inc, SonaCare Medical LLC, BVM Medical Ltd, BTG International Ltd, Mermaid Medical, HistoSonics Inc, Medigus Ltd, Miramar Labs Inc, KLS Martin Group, Endocare Inc, InnovaCore Inc, IceCure Medical Inc, RF Medical Co Ltd, CSA Medical Inc

Access The Complete Oncology Ablation Market Report:

https://www.thebusinessresearchcompany.com/report/oncology-ablation-global-market-report

Oncology Ablation Market Geographic Landscape: Which Region Dominates Industry Growth?

North Americawas the largest region in the oncology ablation market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the oncology ablation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Estimated Growth In Market Size Of The Oncology Ablation Market During 2026–2030?

The oncology ablation market size has seen a rapid increase in recent years. It is anticipated to expand from $1.45 billion in 2025 to $1.64 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 12.5%. The historical growth of this market can be attributed to several factors, including the rising prevalence of liver, kidney, and lung cancers, an increasing demand for minimally invasive treatments, the growing availability of advanced imaging technologies, the expansion of hospitals and specialty oncology centers, and a heightened awareness of ablation as an alternative to surgery.

The oncology ablation market size is projected to experience substantial growth over the next few years. It is forecast to expand to $2.61 billion by 2030, achieving a compound annual growth rate (CAGR) of 12.4%. The expansion during the forecast period is primarily attributed to the rise of targeted and personalized ablation therapies, the increasing adoption of percutaneous and laparoscopic ablation techniques, continuous technological advancements in ablation equipment, the proliferation of oncology centers in emerging regions, and the growing integration of digital patient management and monitoring systems. Major trends for this period include the rising uptake of digital platforms for managing oncology ablation procedures, the expanding integration of AI and machine learning in tumor diagnosis and planning, the increasing implementation of precision medicine and genomic profiling for ablation therapy, the advancement of automation in ablation devices and surgical equipment, and the heightened use of IoT-enabled monitoring for ablation devices and patient outcomes.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18415&type=smp

Which Growth Factors Are Strengthening The Oncology Ablation Market Landscape?

The increasing frequency of cancer diagnoses is projected to stimulate the expansion of the oncology ablation market. Cancer diagnosis involves the identification and confirmation of cancer’s presence through medical assessments, imaging, and pathological examination of tissue samples. The rise in cancer diagnoses stems from multiple contributing factors, such as aging populations, enhanced screening initiatives, heightened public awareness leading to earlier detection, and various environmental influences. Oncology ablation is utilized for treating tumors identified via these diagnoses, offering minimally invasive options to eliminate tumors and improve patient outcomes. For instance, in May 2024, according to the National Cancer Institute, the US-based federal government’s principal agency for cancer research and training, approximately 2,001,140 new cancer cases are expected in the United States in 2024, with prostate, lung, and colorectal cancers making up about 48% of all diagnoses in men. By 2040, the annual count of new cancer cases is forecast to climb to 29.9 million, underscoring a significant future increase in cancer incidence. Furthermore, in June 2022, the American Cancer Society, a US-based non-profit cancer awareness organization, reported around 1.9 million new cancer cases were diagnosed in the USA in 2022. Therefore, the growing number of cancer diagnoses will be a key driver for the oncology ablation market.

What Key Segment Areas Are Included In The Oncology Ablation Market Assessment?

The oncology ablation market covered in this report is segmented –

1) By Technology: Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation

2) By Treatment: Surgical Ablation, Laparoscopic Ablation, Percutaneous Ablation

3) By Application: Kidney Cancer, Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer

Subsegments:

1) By Radiofrequency Ablation: Monopolar Radiofrequency Ablation, Bipolar Radiofrequency Ablation

2) By Microwave Ablation: Single-Probe Microwave Ablation, Multi-Probe Microwave Ablation

3) By Cryoablation: Cryo-Needle Ablation, Cryo-Generator System Ablation

4) By Irreversible Electroporation Ablation: Transurethral IRE, Transperineal IRE, Percutaneous IRE

Which Trends Are Influencing The Expansion Of The Oncology Ablation Market?

Companies operating within the oncologists market are concentrating on establishing AI-precision oncology centers to elevate personalized cancer treatment, improve the accuracy of diagnoses, and optimize treatment strategies by leveraging individual patient data and tumor characteristics. These AI-precision oncology centers are specialized medical facilities that deploy artificial intelligence (AI) and machine learning technologies to deliver highly individualized cancer care. As an illustration, in January 2024, Apollo Cancer Centre, an India-based hospital, launched an Apollo Cancer Centre. This center is designed to assist oncologists, patients, and caregivers in achieving the best possible outcomes within a defined timeframe by harnessing the extensive capabilities of AI technology. The Precision Oncology Centre (POC) employs AI technologies to deliver precise diagnoses and provide real-time insights into patient conditions, thereby enabling timely interventions and better management of cancer cases. Additionally, the center conducts comprehensive cancer risk assessments, which aids in identifying patients who may benefit from targeted therapies or immunotherapy as part of their treatment plans.

Who Are The Businesses Driving Activity In The Oncology Ablation Market?

Major companies operating in the oncology ablation market are Medtronic plc, Boston Scientific Corporation, AngioDynamics Inc, EDAP TMS S.A., Merit Medical Systems Inc, Misonix Inc, BSD Medical Corporation, Sonacare Medical, Chongqing Haifu Medical Technology Co Ltd, HealthTronics Inc, Galil Medical Inc, SonaCare Medical LLC, BVM Medical Ltd, BTG International Ltd, Mermaid Medical, HistoSonics Inc, Medigus Ltd, Miramar Labs Inc, KLS Martin Group, Endocare Inc, InnovaCore Inc, IceCure Medical Inc, RF Medical Co Ltd, CSA Medical Inc

Access The Complete Oncology Ablation Market Report:

https://www.thebusinessresearchcompany.com/report/oncology-ablation-global-market-report

Which Region Is The Dominant Market In The Oncology Ablation Market?

North America was the largest region in the oncology ablation market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oncology ablation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Oncology Ablation Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=18415&type=smp

Browse Through More Reports Similar to the Global Oncology Ablation Market 2026, By The Business Research Company

Therapeutic Dental Equipment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/therapeutic-dental-equipment-global-market-report

Dental Equipment And Supplies Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/dental-equipment-and-supplies-global-market-report

Dental Hygiene Instrument Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/dental-hygiene-instrument-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Market Size Of The Oncology Ablation Market Expected To Scale Between 2026 And 2030?

The oncology ablation market size has experienced rapid growth in recent years. This market is projected to expand from $1.45 billion in 2025 to $1.64 billion in 2026, achieving a compound annual growth rate (CAGR) of 12.5%. Historically, this growth has been driven by factors such as the increasing prevalence of liver, kidney, and lung cancers, a heightened demand for minimally invasive treatments, the wider availability of advanced imaging technologies, the expansion of hospitals and dedicated oncology centers, and a growing understanding of ablation as a viable alternative to surgical procedures.

The oncology ablation market size is projected to experience substantial growth in the coming years, anticipated to reach $2.61 billion by 2030 at a compound annual growth rate (CAGR) of 12.4%. This expansion during the forecast period is attributed to several factors, including the increase in targeted and personalized ablation therapies, the rising adoption of percutaneous and laparoscopic ablation techniques, ongoing technological advancements in ablation equipment, the expansion of oncology centers in emerging regions, and the growing integration of digital patient management and monitoring systems. Key trends for the forecast period include the increasing adoption of digital platforms for managing oncology ablation procedures, the expanding integration of AI and machine learning in tumor diagnosis and planning, the broader implementation of precision medicine and genomic profiling for ablation therapy, the rising automation in ablation devices and surgical equipment, and the increasing use of IoT-enabled monitoring for ablation devices and patient outcomes.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18415&type=smp

What Factors Are Contributing To The Growth Of The Oncology Ablation Market?

The expanding volume of cancer diagnoses is anticipated to fuel the expansion of the oncology ablation market in the foreseeable future. Cancer diagnosis involves identifying and confirming cancer’s presence through various methods, including medical tests, imaging techniques, and the pathological analysis of tissue samples. This surge in diagnoses stems from multiple contributors like aging demographics, enhanced screening initiatives, increased public awareness prompting earlier detection, and environmental influences. Oncology ablation addresses tumors identified via these diagnoses, providing minimally invasive approaches to eliminate tumors and enhance patient outcomes. Illustratively, data from May 2024 by the National Cancer Institute, the primary US federal agency for cancer research and training, projects approximately 2,001,140 new cancer cases in the United States in 2024, with prostate, lung, and colorectal cancers accounting for about 48% of all diagnoses in men. Furthermore, by 2040, the yearly count of new cancer cases is predicted to climb to 29.9 million, underscoring a substantial rise in future cancer occurrences. Additionally, in June 2022, the American Cancer Society, a US non-profit dedicated to cancer awareness, reported about 1.9 million new cancer cases diagnosed in the USA in 2022. Consequently, the growing volume of cancer diagnoses will serve as a key driver for the oncology ablation market.

How Is The Oncology Ablation Market Organized By Segment Classification?

The oncology ablation market covered in this report is segmented –

1) By Technology: Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation

2) By Treatment: Surgical Ablation, Laparoscopic Ablation, Percutaneous Ablation

3) By Application: Kidney Cancer, Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer

Subsegments:

1) By Radiofrequency Ablation: Monopolar Radiofrequency Ablation, Bipolar Radiofrequency Ablation

2) By Microwave Ablation: Single-Probe Microwave Ablation, Multi-Probe Microwave Ablation

3) By Cryoablation: Cryo-Needle Ablation, Cryo-Generator System Ablation

4) By Irreversible Electroporation Ablation: Transurethral IRE, Transperineal IRE, Percutaneous IRE

What Trends Are Shaping The Future Of The Oncology Ablation Market?

Leading companies within the oncology ablation market are introducing innovative products, including advanced ablation systems offering enhanced precision, integrated imaging solutions for real-time guidance, and improved safety functionalities. These advanced ablation systems with improved precision are medical instruments that employ cutting-edge technology to accurately pinpoint and eliminate abnormal tissue, like tumors, thereby reducing harm to adjacent healthy tissue. As an illustration, in March 2024, Medtronic Plc, an Ireland-based medical equipment manufacturing company, secured US Food and Drug Administration approval for its OsteoCool 2.0 bone tumor ablation system, which is engineered to address painful bone metastases and benign tumors such as osteoid osteoma. The upgraded system incorporates substantial improvements, notably the capacity to simultaneously utilize four internally cooled probes, facilitating the ablation of two vertebral bodies concurrently or the generation of larger ablation zones in non-spinal contexts.

Who Are The Industry Participants Involved In The Oncology Ablation Market?

Major companies operating in the oncology ablation market are Medtronic plc, Boston Scientific Corporation, AngioDynamics Inc, EDAP TMS S.A., Merit Medical Systems Inc, Misonix Inc, BSD Medical Corporation, Sonacare Medical, Chongqing Haifu Medical Technology Co Ltd, HealthTronics Inc, Galil Medical Inc, SonaCare Medical LLC, BVM Medical Ltd, BTG International Ltd, Mermaid Medical, HistoSonics Inc, Medigus Ltd, Miramar Labs Inc, KLS Martin Group, Endocare Inc, InnovaCore Inc, IceCure Medical Inc, RF Medical Co Ltd, CSA Medical Inc

Get The Full Oncology Ablation Market Report:

https://www.thebusinessresearchcompany.com/report/oncology-ablation-global-market-report

Which Geographic Region Dominates The Oncology Ablation Market?

North America was the largest region in the oncology ablation market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oncology ablation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Oncology Ablation Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/oncology-ablation-global-market-report

Browse Through More Reports Similar to the Global Oncology Ablation Market 2026, By The Business Research Company

Therapeutic Dental Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/therapeutic-dental-equipment-global-market-report

Dental Equipment And Supplies Market Report

https://www.thebusinessresearchcompany.com/report/dental-equipment-and-supplies-global-market-report

Dental Hygiene Instrument Market Report

https://www.thebusinessresearchcompany.com/report/dental-hygiene-instrument-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Valuation Is Forecasted For The Oncology Ablation Market By 2030 Starting From Its 2026 Size?

The oncology ablation market has seen rapid expansion in recent years. Its value is projected to increase from $1.45 billion in 2025 to $1.64 billion in 2026, reflecting a compound annual growth rate (CAGR) of 12.5%. This historical growth can be ascribed to the increasing occurrence of liver, kidney, and lung cancers, a rising demand for minimally invasive treatments, the enhanced availability of advanced imaging technologies, the establishment of more hospitals and specialty oncology centers, and growing awareness of ablation as an alternative to surgery.

The oncology ablation market is projected to experience substantial expansion in the coming years. By 2030, this market is anticipated to reach $2.61 billion, expanding at a compound annual growth rate (CAGR) of 12.4%. This projected growth is driven by several factors, including the rise of targeted and personalized ablation treatments, the increased acceptance of percutaneous and laparoscopic ablation methods, continuous technological progress in ablation devices, the expansion of oncology facilities in developing areas, and the growing incorporation of digital systems for patient management and monitoring. Key trends expected during this period involve the increasing use of digital platforms for managing oncology ablation procedures, the greater integration of AI and machine learning in tumor diagnosis and treatment planning, the expanding application of precision medicine and genomic profiling in ablation therapy, enhanced automation within ablation devices and surgical instruments, and the growing deployment of IoT-enabled monitoring for ablation devices and patient results.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18415&type=smp

What Primary Drivers Are Shaping The Development Of The Oncology Ablation Market?

The rising number of cancer diagnoses is anticipated to propel the growth of the oncology ablation market going forward. Cancer diagnosis involves identifying and confirming the presence of cancer through medical tests, imaging, and pathological analysis of tissue samples. This increase in cancer diagnoses is attributed to several factors, including aging populations, enhanced screening programs, heightened awareness leading to earlier detection, and environmental factors. Oncology ablation is utilized to treat tumors identified via cancer diagnoses, offering minimally invasive options to destroy tumors and improve patient outcomes. For example, in May 2024, the National Cancer Institute, the US-based federal government’s principal agency for cancer research and training, projected approximately 2,001,140 new cancer cases in the United States in 2024, with prostate, lung, and colorectal cancers collectively making up around 48% of all diagnoses in men. By 2040, the annual number of new cancer cases is expected to surge to 29.9 million, indicating a significant future increase in cancer incidence. Furthermore, in June 2022, the American Cancer Society, a US-based non-profit cancer awareness organization, reported that about 1.9 million new cancer cases were diagnosed in the USA in 2022. Therefore, the increasing number of cancer diagnoses will drive the oncology ablation market.

Which Segment Categories Define The Oncology Ablation Market?

The oncology ablation market covered in this report is segmented –

1) By Technology: Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation

2) By Treatment: Surgical Ablation, Laparoscopic Ablation, Percutaneous Ablation

3) By Application: Kidney Cancer, Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer

Subsegments:

1) By Radiofrequency Ablation: Monopolar Radiofrequency Ablation, Bipolar Radiofrequency Ablation

2) By Microwave Ablation: Single-Probe Microwave Ablation, Multi-Probe Microwave Ablation

3) By Cryoablation: Cryo-Needle Ablation, Cryo-Generator System Ablation

4) By Irreversible Electroporation Ablation: Transurethral IRE, Transperineal IRE, Percutaneous IRE

What Key Trends Are Influencing The Development Of The Oncology Ablation Market?

Leading companies in the oncology ablation market are developing innovative products, such as advanced ablation systems with enhanced precision, integrated imaging technologies for real-time guidance, and improved safety features. These advanced ablation systems, known for their improved precision, are medical devices that leverage sophisticated technology to accurately target and destroy abnormal tissue, like tumors, while minimizing damage to healthy surrounding tissue. For example, in March 2024, Medtronic Plc, an Ireland-based medical equipment manufacturing company, obtained US Food and Drug Administration approval for the OsteoCool 2.0 bone tumor ablation system, which is designed to treat painful bone metastases and benign tumors such as osteoid osteoma. This updated system includes significant enhancements, notably the capability to use four internally cooled probes simultaneously, which facilitates the ablation of two vertebral bodies at once or the creation of larger ablation zones in non-spinal applications.

Who Are The Top Companies Competing In The Oncology Ablation Market?

Major companies operating in the oncology ablation market are Medtronic plc, Boston Scientific Corporation, AngioDynamics Inc, EDAP TMS S.A., Merit Medical Systems Inc, Misonix Inc, BSD Medical Corporation, Sonacare Medical, Chongqing Haifu Medical Technology Co Ltd, HealthTronics Inc, Galil Medical Inc, SonaCare Medical LLC, BVM Medical Ltd, BTG International Ltd, Mermaid Medical, HistoSonics Inc, Medigus Ltd, Miramar Labs Inc, KLS Martin Group, Endocare Inc, InnovaCore Inc, IceCure Medical Inc, RF Medical Co Ltd, CSA Medical Inc

Read the full oncology ablation market report here:

https://www.thebusinessresearchcompany.com/report/oncology-ablation-global-market-report

How Does The Oncology Ablation Market Perform Across Major Global Regions?

North America was the largest region in the oncology ablation market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oncology ablation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Oncology Ablation Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=18415&type=smp

Browse Through More Reports Similar to the Global Oncology Ablation Market 2026, By The Business Research Company

Therapeutic Dental Equipment Global Market Report

https://www.thebusinessresearchcompany.com/report/therapeutic-dental-equipment-global-market-report

Dental Equipment And Supplies Global Market Report

https://www.thebusinessresearchcompany.com/report/dental-equipment-and-supplies-global-market-report

Dental Hygiene Instrument Global Market Report

https://www.thebusinessresearchcompany.com/report/dental-hygiene-instrument-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Valuation Is Forecasted For The Oncology Ablation Market By 2030 Starting From Its 2026 Size?

The oncology ablation market has seen rapid expansion in recent years. Its value is projected to increase from $1.45 billion in 2025 to $1.64 billion in 2026, reflecting a compound annual growth rate (CAGR) of 12.5%. This historical growth can be ascribed to the increasing occurrence of liver, kidney, and lung cancers, a rising demand for minimally invasive treatments, the enhanced availability of advanced imaging technologies, the establishment of more hospitals and specialty oncology centers, and growing awareness of ablation as an alternative to surgery.

The oncology ablation market is projected to experience substantial expansion in the coming years. By 2030, this market is anticipated to reach $2.61 billion, expanding at a compound annual growth rate (CAGR) of 12.4%. This projected growth is driven by several factors, including the rise of targeted and personalized ablation treatments, the increased acceptance of percutaneous and laparoscopic ablation methods, continuous technological progress in ablation devices, the expansion of oncology facilities in developing areas, and the growing incorporation of digital systems for patient management and monitoring. Key trends expected during this period involve the increasing use of digital platforms for managing oncology ablation procedures, the greater integration of AI and machine learning in tumor diagnosis and treatment planning, the expanding application of precision medicine and genomic profiling in ablation therapy, enhanced automation within ablation devices and surgical instruments, and the growing deployment of IoT-enabled monitoring for ablation devices and patient results.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18415&type=smp

What Primary Drivers Are Shaping The Development Of The Oncology Ablation Market?

The rising number of cancer diagnoses is anticipated to propel the growth of the oncology ablation market going forward. Cancer diagnosis involves identifying and confirming the presence of cancer through medical tests, imaging, and pathological analysis of tissue samples. This increase in cancer diagnoses is attributed to several factors, including aging populations, enhanced screening programs, heightened awareness leading to earlier detection, and environmental factors. Oncology ablation is utilized to treat tumors identified via cancer diagnoses, offering minimally invasive options to destroy tumors and improve patient outcomes. For example, in May 2024, the National Cancer Institute, the US-based federal government’s principal agency for cancer research and training, projected approximately 2,001,140 new cancer cases in the United States in 2024, with prostate, lung, and colorectal cancers collectively making up around 48% of all diagnoses in men. By 2040, the annual number of new cancer cases is expected to surge to 29.9 million, indicating a significant future increase in cancer incidence. Furthermore, in June 2022, the American Cancer Society, a US-based non-profit cancer awareness organization, reported that about 1.9 million new cancer cases were diagnosed in the USA in 2022. Therefore, the increasing number of cancer diagnoses will drive the oncology ablation market.

Which Segment Categories Define The Oncology Ablation Market?

The oncology ablation market covered in this report is segmented –

1) By Technology: Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation

2) By Treatment: Surgical Ablation, Laparoscopic Ablation, Percutaneous Ablation

3) By Application: Kidney Cancer, Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer

Subsegments:

1) By Radiofrequency Ablation: Monopolar Radiofrequency Ablation, Bipolar Radiofrequency Ablation

2) By Microwave Ablation: Single-Probe Microwave Ablation, Multi-Probe Microwave Ablation

3) By Cryoablation: Cryo-Needle Ablation, Cryo-Generator System Ablation

4) By Irreversible Electroporation Ablation: Transurethral IRE, Transperineal IRE, Percutaneous IRE

What Key Trends Are Influencing The Development Of The Oncology Ablation Market?

Leading companies in the oncology ablation market are developing innovative products, such as advanced ablation systems with enhanced precision, integrated imaging technologies for real-time guidance, and improved safety features. These advanced ablation systems, known for their improved precision, are medical devices that leverage sophisticated technology to accurately target and destroy abnormal tissue, like tumors, while minimizing damage to healthy surrounding tissue. For example, in March 2024, Medtronic Plc, an Ireland-based medical equipment manufacturing company, obtained US Food and Drug Administration approval for the OsteoCool 2.0 bone tumor ablation system, which is designed to treat painful bone metastases and benign tumors such as osteoid osteoma. This updated system includes significant enhancements, notably the capability to use four internally cooled probes simultaneously, which facilitates the ablation of two vertebral bodies at once or the creation of larger ablation zones in non-spinal applications.

Who Are The Top Companies Competing In The Oncology Ablation Market?

Major companies operating in the oncology ablation market are Medtronic plc, Boston Scientific Corporation, AngioDynamics Inc, EDAP TMS S.A., Merit Medical Systems Inc, Misonix Inc, BSD Medical Corporation, Sonacare Medical, Chongqing Haifu Medical Technology Co Ltd, HealthTronics Inc, Galil Medical Inc, SonaCare Medical LLC, BVM Medical Ltd, BTG International Ltd, Mermaid Medical, HistoSonics Inc, Medigus Ltd, Miramar Labs Inc, KLS Martin Group, Endocare Inc, InnovaCore Inc, IceCure Medical Inc, RF Medical Co Ltd, CSA Medical Inc

Read the full oncology ablation market report here:

https://www.thebusinessresearchcompany.com/report/oncology-ablation-global-market-report

How Does The Oncology Ablation Market Perform Across Major Global Regions?

North America was the largest region in the oncology ablation market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oncology ablation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Oncology Ablation Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=18415&type=smp

Browse Through More Reports Similar to the Global Oncology Ablation Market 2026, By The Business Research Company

Therapeutic Dental Equipment Global Market Report

https://www.thebusinessresearchcompany.com/report/therapeutic-dental-equipment-global-market-report

Dental Equipment And Supplies Global Market Report

https://www.thebusinessresearchcompany.com/report/dental-equipment-and-supplies-global-market-report

Dental Hygiene Instrument Global Market Report

https://www.thebusinessresearchcompany.com/report/dental-hygiene-instrument-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Valuation Is Forecasted For The Oncology Ablation Market By 2030 Starting From Its 2026 Size?

The oncology ablation market has seen rapid expansion in recent years. Its value is projected to increase from $1.45 billion in 2025 to $1.64 billion in 2026, reflecting a compound annual growth rate (CAGR) of 12.5%. This historical growth can be ascribed to the increasing occurrence of liver, kidney, and lung cancers, a rising demand for minimally invasive treatments, the enhanced availability of advanced imaging technologies, the establishment of more hospitals and specialty oncology centers, and growing awareness of ablation as an alternative to surgery.

The oncology ablation market is projected to experience substantial expansion in the coming years. By 2030, this market is anticipated to reach $2.61 billion, expanding at a compound annual growth rate (CAGR) of 12.4%. This projected growth is driven by several factors, including the rise of targeted and personalized ablation treatments, the increased acceptance of percutaneous and laparoscopic ablation methods, continuous technological progress in ablation devices, the expansion of oncology facilities in developing areas, and the growing incorporation of digital systems for patient management and monitoring. Key trends expected during this period involve the increasing use of digital platforms for managing oncology ablation procedures, the greater integration of AI and machine learning in tumor diagnosis and treatment planning, the expanding application of precision medicine and genomic profiling in ablation therapy, enhanced automation within ablation devices and surgical instruments, and the growing deployment of IoT-enabled monitoring for ablation devices and patient results.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18415&type=smp

What Primary Drivers Are Shaping The Development Of The Oncology Ablation Market?

The rising number of cancer diagnoses is anticipated to propel the growth of the oncology ablation market going forward. Cancer diagnosis involves identifying and confirming the presence of cancer through medical tests, imaging, and pathological analysis of tissue samples. This increase in cancer diagnoses is attributed to several factors, including aging populations, enhanced screening programs, heightened awareness leading to earlier detection, and environmental factors. Oncology ablation is utilized to treat tumors identified via cancer diagnoses, offering minimally invasive options to destroy tumors and improve patient outcomes. For example, in May 2024, the National Cancer Institute, the US-based federal government’s principal agency for cancer research and training, projected approximately 2,001,140 new cancer cases in the United States in 2024, with prostate, lung, and colorectal cancers collectively making up around 48% of all diagnoses in men. By 2040, the annual number of new cancer cases is expected to surge to 29.9 million, indicating a significant future increase in cancer incidence. Furthermore, in June 2022, the American Cancer Society, a US-based non-profit cancer awareness organization, reported that about 1.9 million new cancer cases were diagnosed in the USA in 2022. Therefore, the increasing number of cancer diagnoses will drive the oncology ablation market.

Which Segment Categories Define The Oncology Ablation Market?

The oncology ablation market covered in this report is segmented –

1) By Technology: Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation

2) By Treatment: Surgical Ablation, Laparoscopic Ablation, Percutaneous Ablation

3) By Application: Kidney Cancer, Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer

Subsegments:

1) By Radiofrequency Ablation: Monopolar Radiofrequency Ablation, Bipolar Radiofrequency Ablation

2) By Microwave Ablation: Single-Probe Microwave Ablation, Multi-Probe Microwave Ablation

3) By Cryoablation: Cryo-Needle Ablation, Cryo-Generator System Ablation

4) By Irreversible Electroporation Ablation: Transurethral IRE, Transperineal IRE, Percutaneous IRE

What Key Trends Are Influencing The Development Of The Oncology Ablation Market?

Leading companies in the oncology ablation market are developing innovative products, such as advanced ablation systems with enhanced precision, integrated imaging technologies for real-time guidance, and improved safety features. These advanced ablation systems, known for their improved precision, are medical devices that leverage sophisticated technology to accurately target and destroy abnormal tissue, like tumors, while minimizing damage to healthy surrounding tissue. For example, in March 2024, Medtronic Plc, an Ireland-based medical equipment manufacturing company, obtained US Food and Drug Administration approval for the OsteoCool 2.0 bone tumor ablation system, which is designed to treat painful bone metastases and benign tumors such as osteoid osteoma. This updated system includes significant enhancements, notably the capability to use four internally cooled probes simultaneously, which facilitates the ablation of two vertebral bodies at once or the creation of larger ablation zones in non-spinal applications.

Who Are The Top Companies Competing In The Oncology Ablation Market?

Major companies operating in the oncology ablation market are Medtronic plc, Boston Scientific Corporation, AngioDynamics Inc, EDAP TMS S.A., Merit Medical Systems Inc, Misonix Inc, BSD Medical Corporation, Sonacare Medical, Chongqing Haifu Medical Technology Co Ltd, HealthTronics Inc, Galil Medical Inc, SonaCare Medical LLC, BVM Medical Ltd, BTG International Ltd, Mermaid Medical, HistoSonics Inc, Medigus Ltd, Miramar Labs Inc, KLS Martin Group, Endocare Inc, InnovaCore Inc, IceCure Medical Inc, RF Medical Co Ltd, CSA Medical Inc

Read the full oncology ablation market report here:

https://www.thebusinessresearchcompany.com/report/oncology-ablation-global-market-report

How Does The Oncology Ablation Market Perform Across Major Global Regions?

North America was the largest region in the oncology ablation market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oncology ablation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Oncology Ablation Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=18415&type=smp

Browse Through More Reports Similar to the Global Oncology Ablation Market 2026, By The Business Research Company

Therapeutic Dental Equipment Global Market Report

https://www.thebusinessresearchcompany.com/report/therapeutic-dental-equipment-global-market-report

Dental Equipment And Supplies Global Market Report

https://www.thebusinessresearchcompany.com/report/dental-equipment-and-supplies-global-market-report

Dental Hygiene Instrument Global Market Report

https://www.thebusinessresearchcompany.com/report/dental-hygiene-instrument-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the oncology ablation market from 2026–2035 with trusted insights from The Business Research Company

How much is the Oncology Ablation Market valued at in 2026, and what valuation is forecast for 2030?

The oncology ablation market size has witnessed rapid growth in recent years. This market is set to increase from $1.45 billion in 2025 to $1.64 billion in 2026, achieving a compound annual growth rate (CAGR) of 12.5%. The historical growth of this market is attributable to the rising prevalence of liver, kidney, and lung cancers, an increasing demand for minimally invasive treatments, the growing availability of advanced imaging technologies, the expansion of hospitals and specialty oncology centers, and a greater awareness of ablation as an alternative to surgery.

The oncology ablation market is projected to experience substantial expansion over the upcoming years, reaching a valuation of $2.61 billion by 2030, driven by a compound annual growth rate (CAGR) of 12.4%. This anticipated growth during the forecast period is primarily fueled by several factors, including the development of targeted and individualized ablation treatments, the rising preference for percutaneous and laparoscopic ablation methods, continuous technological improvements in ablation devices, the proliferation of oncology facilities in developing areas, and the increased incorporation of digital platforms for patient care and oversight. Key trends anticipated for this period encompass the greater use of digital solutions for managing oncology ablation procedures, the growing incorporation of AI and machine learning for tumor detection and treatment planning, the expanded application of precision medicine and genomic profiling in ablation treatments, enhanced automation within ablation devices and surgical tools, and the increasing reliance on IoT-enabled monitoring for ablation equipment and patient results.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18415&type=smp

What Drivers Are Influencing The Growth Of The Oncology Ablation Market?

The anticipated rise in cancer diagnoses is poised to drive the expansion of the oncology ablation market. Cancer diagnosis involves identifying and confirming the existence of cancer through medical examinations, imaging techniques, and detailed pathological analysis of tissue samples. This increase in cancer diagnoses can be attributed to multiple factors, such as an aging demographic, improvements in screening programs, heightened public awareness leading to earlier detection, and environmental elements. Oncology ablation serves to treat tumors identified through these diagnoses, offering minimally invasive procedures to eliminate tumors and enhance patient prognoses. For instance, in May 2024, the National Cancer Institute, the US-based federal government’s principal agency for cancer research, estimated around 2,001,140 new cancer cases in the United States in 2024, with prostate, lung, and colorectal cancers collectively representing approximately 48% of all diagnoses in men. Projections indicate a significant surge in the annual number of new cancer cases to 29.9 million by 2040, highlighting a substantial future growth in cancer incidence. Furthermore, in June 2022, the American Cancer Society, a US-based non-profit cancer awareness organization, reported about 1.9 million new cancer cases diagnosed in the USA in 2022. Therefore, the growing number of cancer diagnoses will be a significant catalyst for the oncology ablation market.

What Segments Are Included Within The Oncology Ablation Market?

The oncology ablation market covered in this report is segmented –

1) By Technology: Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation

2) By Treatment: Surgical Ablation, Laparoscopic Ablation, Percutaneous Ablation

3) By Application: Kidney Cancer, Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer

Subsegments:

1) By Radiofrequency Ablation: Monopolar Radiofrequency Ablation, Bipolar Radiofrequency Ablation

2) By Microwave Ablation: Single-Probe Microwave Ablation, Multi-Probe Microwave Ablation

3) By Cryoablation: Cryo-Needle Ablation, Cryo-Generator System Ablation

4) By Irreversible Electroporation Ablation: Transurethral IRE, Transperineal IRE, Percutaneous IRE

Which Market Trends Are Opening Growth Opportunities In The Oncology Ablation Market?

Leading companies in the oncology ablation market are innovating products such as advanced ablation systems that offer improved precision, integrated imaging technologies for real-time guidance, and enhanced safety features. Advanced ablation systems with improved precision are medical devices employing sophisticated technology to accurately target and destroy abnormal tissue, like tumors, while minimizing damage to surrounding healthy tissue. For example, in March 2024, Medtronic Plc, an Ireland-based medical equipment manufacturing company, secured US Food and Drug Administration approval for the OsteoCool 2.0 bone tumor ablation system, engineered to manage painful bone metastases and benign tumors such as osteoid osteoma. This enhanced system incorporates notable improvements, including the capability to utilize four internally cooled probes simultaneously, thereby enabling the ablation of two vertebral bodies at once or the creation of larger ablation zones in non-spinal applications.

Who Are The Primary Competitors In The Global Oncology Ablation Market?

Major companies operating in the oncology ablation market are Medtronic plc, Boston Scientific Corporation, AngioDynamics Inc, EDAP TMS S.A., Merit Medical Systems Inc, Misonix Inc, BSD Medical Corporation, Sonacare Medical, Chongqing Haifu Medical Technology Co Ltd, HealthTronics Inc, Galil Medical Inc, SonaCare Medical LLC, BVM Medical Ltd, BTG International Ltd, Mermaid Medical, HistoSonics Inc, Medigus Ltd, Miramar Labs Inc, KLS Martin Group, Endocare Inc, InnovaCore Inc, IceCure Medical Inc, RF Medical Co Ltd, CSA Medical Inc

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/oncology-ablation-global-market-report

Which Regions Are Poised For Strategic Growth In The Oncology Ablation Market?

North America was the largest region in the oncology ablation market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oncology ablation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Oncology Ablation Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=18415&type=smp

Browse Through More Reports Similar to the Global Oncology Ablation Market 2026, By The Business Research Company

Ablation Technology Market Report 2026

https://www.thebusinessresearchcompany.com/report/ablation-technology-global-market-report

Tumor Ablation Market Report 2026

https://www.thebusinessresearchcompany.com/report/tumor-ablation-global-market-report

Tumor Ablation Therapy Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/tumor-ablation-therapy-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model